Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?
Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance?
Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance?